Dopamine D2, cannabinoid CB1, metabotropic glutamate mGlu2 and mGlu3 receptor protein expression in the prefrontal cortex of subjects with schizophrenia

被引:0
作者
DelaCuesta-Barrutia, J. [1 ]
Penagarikano, O. [2 ,3 ]
Morentin, B. [4 ,5 ]
Callado, L. F. [2 ,3 ,5 ]
Meana, J. J. [2 ,3 ,5 ]
Erdozain, A. M. [2 ,3 ]
Ramos-Miguel, A. [2 ,3 ,6 ]
机构
[1] Univ Basque Country UPV EHU, Dept Pharmacol, Leioa Bizkaia, Spain
[2] Univ Basque Country UPV EHU, Dept Pharmacol, Leioa Bizkaia, Spain
[3] Univ Basque Country UPV EHU, Ctr Invest Biomed Red Salud Mental CIBERSA, Leioa Bizkaia, Spain
[4] Basque Inst Legal Med, Sect Forens Pathol, Bilbao, Bizkaia, Spain
[5] Biocruces Bizkaia Hlth Res Inst, Baracaldo, Bizkaia, Spain
[6] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
关键词
D O I
10.1016/j.euroneuro.2021.10.456
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.0484
引用
收藏
页码:S356 / S357
页数:2
相关论文
共 3 条
[1]   Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study [J].
Garcia-Bea, Aintzane ;
Walker, Mary A. ;
Hyde, Thomas M. ;
Kleinman, Joel E. ;
Harrison, Paul J. ;
Lane, Tracy A. .
SCHIZOPHRENIA RESEARCH, 2016, 177 (1-3) :18-27
[2]   Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice [J].
Stojanovic, Tamara ;
Orlova, Michaela ;
Sialana, Fernando J. ;
Hoeger, Harald ;
Stuchlik, Stanislav ;
Milenkovic, Ivan ;
Aradska, Jana ;
Lubec, Gert .
AMINO ACIDS, 2017, 49 (06) :1101-1109
[3]   Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment [J].
Uriguen, Leyre ;
Julia Garcia-Fuster, M. ;
Callado, Luis F. ;
Morentin, Benito ;
La Harpe, Romano ;
Casado, Vicent ;
Lluis, Carmen ;
Franco, Rafael ;
Garcia-Sevilla, Jesus A. ;
Javier Meana, J. .
PSYCHOPHARMACOLOGY, 2009, 206 (02) :313-324